Envision Value & Access is an exhibitor and platinum sponsor at ISPOR EU 2022. As an insight-driven strategic consulting partner for clients and with a full array of HEOR and access services, from the development of your HEOR strategy and RWE roadmap through to evidence generation and communication, we work across functions to develop, communicate, and capture the value of products through a coherent and integrated payer strategy to improve patient access and outcomes globally.
Come meet Suki Kandola, Joe Merkert, and other Envision Value & Access team members at ISPOR Europe 2022, Booth X2-210!
November 6-9; Vienna, Austria
Want to meet at a specific day and time at the event? Then send a message to: value@envisionpharma.com
Envision Value & Access has the following posters presented at ISPOR Europe 2022:
“Deprivation and Access to Care Among Patients with Melanoma in the UK”
Vitaccess Ltd: Casey Quinn and Mark Larkin, Pfizer: Ira Jacobs, Envision Pharma Group: Suki Kandola and Karen E. Smoyer
“A Comparison of the Evolution of Payer Management Practices in Oncology in the United States, Germany, France, and the United Kingdom, Over the Past Five Years”
Envision Pharma Group: Anne Runyan, Janice Yi, Mounika Bodagala, Milos Pavic, and Thomas Schoenwaelder
“Investigating How Orphan Drug Manufacturers Can Optimize Clinical Trial Design so Patients across Geographies Can Access Life-Saving Innovations”
Envision Pharma Group: Sheli Goldstein, Anne Runyan, Joe Merkert, Thomas Schoenwaelder, and Milos Pavic